Feb 25, 2020
Kinnari Patel, Chief Operating Officer, Rocket Pharmaceuticals discusses how Rocket is focused on creating new options for patients contending with rare genetic diseases. Rocket is advancing several gene therapies for rare pediatric diseases and Kinnari provides insights into how the company is tackling the unique challenges facing patients with rare diseases, their caregivers and the community at large. This February 29th Rocket Pharma is hosting a Rare Disease Day event featuring patient discussions and opportunities for patients and families to engage with physicians and researchers in the NY healthcare community.
@RocketPharma
#RareDiseaseDay #RareDiseases #GeneticDisease #GeneTherapy #FanconiAnemia #DanonDisease #PatientFocused